1-Benzyl-5-bromo-3-hydrazonoindolin-2-ones as Novel Anticancer Agents: Synthesis, Biological Evaluation and Molecular Modeling Insights.

Abstract

Human health is experiencing several obstacles in the modern medical era, particularly cancer. As a result, the cancer therapeutic arsenal should be continually expanded with innovative small molecules that preferentially target tumour cells. In this study, we describe the development of two small molecule series (7a-d and 12a-e) based on the 1-benzyl-5-bromoindolin-2-one scaffold that connected through a hydrazone linker to a 4-arylthiazole (7a-d) or 4-methyl-5-(aryldiazenyl)thiazole (12a-e) moiety. The anticancer activity of all the reported indolin-2-one derivatives was assessed against breast (MCF-7) and lung (A-549) cancer cell lines. The 4-arylthiazole-bearing derivatives 7c and 7d revealed the best anticancer activity toward MCF-7 cells (IC50 = 7.17 ± 0.94 and 2.93 ± 0.47, respectively). Furthermore, the VEGFR-2 inhibitory activity for 7c and 7d was evaluated. Both molecules disclosed good inhibitory activity, and their IC50 values were equal to 0.728 µM and 0.503 µM, respectively. Additionally, the impacts of 7d on the cell cycle phases as well as on the levels of different apoptotic markers (caspase-3, caspase-9, Bax, and Bcl-2) were assessed. Molecular docking and dynamic simulations are carried out to explore the binding mode of 7d within the VEGFR-2 active site.

• Authors: Tarfah Al-Warhi, Hadia Almahli, Raed M Maklad, Zainab M Elsayed, Mahmoud A El Hassab, Ohoud J Alotaibi, Nada Aljaeed, Rezk R Ayyad, Hazem A Ghabour, Wagdy M Eldehna, Mohamed K El-Ashrey
• Journal: Molecules (Basel, Switzerland) (Molecules) Vol. 28 Issue 7 (Apr 04 2023) ISSN: 1420-3049 [Electronic] Switzerland
• PMID: 37049966 (Publication Type: Journal Article)

Chemical References

• Vascular Endothelial Growth Factor Receptor-2
• Antineoplastic Agents
• Protein Kinase Inhibitors

Topics

• Humans
• Molecular Structure
• Structure-Activity Relationship
• Vascular Endothelial Growth Factor Receptor-2
• Molecular Docking Simulation
• Cell Proliferation
• Antineoplastic Agents (chemistry)
• MCF-7 Cells
• Drug Screening Assays, Antitumor
• Protein Kinase Inhibitors (pharmacology)